UY38939A - Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva - Google Patents
Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportivaInfo
- Publication number
- UY38939A UY38939A UY0001038939A UY38939A UY38939A UY 38939 A UY38939 A UY 38939A UY 0001038939 A UY0001038939 A UY 0001038939A UY 38939 A UY38939 A UY 38939A UY 38939 A UY38939 A UY 38939A
- Authority
- UY
- Uruguay
- Prior art keywords
- methods
- compositions
- sports medicine
- medicine applications
- cannabinoid compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229930003827 cannabinoid Natural products 0.000 title abstract 2
- 239000003557 cannabinoid Substances 0.000 title abstract 2
- 239000003921 oil Substances 0.000 abstract 2
- 235000019198 oils Nutrition 0.000 abstract 2
- 206010007710 Cartilage injury Diseases 0.000 abstract 1
- 206010060820 Joint injury Diseases 0.000 abstract 1
- 208000029549 Muscle injury Diseases 0.000 abstract 1
- 208000021945 Tendon injury Diseases 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 235000019864 coconut oil Nutrition 0.000 abstract 1
- 239000003240 coconut oil Substances 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Se proporcionan composiciones que comprenden un cannabinoide, un aceite (por ejemplo, aceite MCT o aceite de coco) y una cera, y métodos para preparar tales composiciones. Las composiciones divulgadas pueden ser útiles, por ejemplo, en el tratamiento de una lesión del músculo, articulación, cartílago y/o tendón. Este resumen está destinado a ser una herramienta de exploración con el propósito de buscar en la técnica particular y no pretende ser una limitación de la presente invención.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962928206P | 2019-10-30 | 2019-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY38939A true UY38939A (es) | 2022-04-29 |
Family
ID=75686693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001038939A UY38939A (es) | 2019-10-30 | 2020-10-30 | Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva |
Country Status (4)
Country | Link |
---|---|
US (1) | US20210128521A1 (es) |
AR (1) | AR120350A1 (es) |
UY (1) | UY38939A (es) |
WO (1) | WO2021086964A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11058142B1 (en) | 2020-10-01 | 2021-07-13 | Tobacco Technology, Inc. | Shisha, heat-not-burn, or combustion casing with active ingredient, product and casing with active ingredient, and method of making the same |
US11363834B2 (en) | 2020-10-01 | 2022-06-21 | Tobacco Technology, Inc. | Shisha, heat-not-burn, or combustion casing, product, and method of making the same |
CA3235080A1 (en) | 2021-10-26 | 2023-04-05 | Alexandra M CAPANO | Methods of treating endometriosis and other non-cancer gynecological disorders with hemp extract |
CA3235074A1 (en) | 2021-10-26 | 2023-05-04 | Alexandra M CAPANO | Methods of treating ovarian cancer with hemp extract |
EP4422769A2 (en) | 2021-10-26 | 2024-09-04 | Ecofibre USA Inc. | Systems and methods for producing hemp extracts and compositions |
US12011451B2 (en) | 2022-10-26 | 2024-06-18 | Ecofibre USA Inc. | Stabilized compositions comprising cannabidiol |
US12097211B2 (en) | 2022-10-26 | 2024-09-24 | Ecofibre USA Inc. | Methods of treating estrogen sensitive diseases with cannabis extract |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6949582B1 (en) * | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
US10052339B2 (en) * | 2014-03-21 | 2018-08-21 | Bodybio Inc. | Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids |
US20160338974A1 (en) * | 2015-03-02 | 2016-11-24 | Afgin Pharma, Llc | Topical regional neuro affective therapy with cannabinoid combination products |
ES2977485T3 (es) * | 2018-03-14 | 2024-08-26 | Poviva Corp | Administración transdérmica y/o dérmica de agentes activos lipofílicos |
WO2019186544A1 (en) * | 2018-03-26 | 2019-10-03 | Raphael Luxenbourg | Topical cannabidiol compositions and methods for protecting the skin from ultra-violet radiation |
-
2020
- 2020-10-28 US US17/082,915 patent/US20210128521A1/en not_active Abandoned
- 2020-10-28 WO PCT/US2020/057736 patent/WO2021086964A1/en active Application Filing
- 2020-10-30 AR ARP200103006A patent/AR120350A1/es unknown
- 2020-10-30 UY UY0001038939A patent/UY38939A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2021086964A1 (en) | 2021-05-06 |
US20210128521A1 (en) | 2021-05-06 |
AR120350A1 (es) | 2022-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY38939A (es) | Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva | |
SV2017005471A (es) | Derivados de quinazolina utilizados para tratar el vih | |
DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
CO2020005887A2 (es) | Compuestos policíclicos como inhibidores alostéricos de shp2 | |
CL2020002841A1 (es) | Compuestos inhibidores de rip1 y métodos para preparar y usar los mismos | |
ECSP19015192A (es) | Composiciones y métodos de inhibir masp-3 para el tratamiento de diversas enfermedades y trastornos | |
UY38237A (es) | Derivados sustituidos de la carboxamida dihidropirazolo pirazina | |
BR112022016382A2 (pt) | Triptaminas específicas para o uso no tratamento de doenças do humor | |
BR112017012184A2 (pt) | composições e métodos para reticular polímeros na presença de oxigênio atmosférico | |
BR112018073711A2 (pt) | dispositivo de distração osteogênica telescópico intracorporal, dispositivo de produção de força extracorporal, método de alongamento de osso e disposição de alongamento de osso | |
AR101656A1 (es) | Materiales biofotónicos a base de silicona y usos de los mismos | |
CO2023013397A2 (es) | Compuestos de tienopirrol | |
CL2020001349A1 (es) | Compuestos, composición y uso de los mismos como moduladores de la expresión de pcsk9. (divisional solicitud 201902574) | |
PE20181203A1 (es) | Derivados de fenilo como agonistas de receptor de cannabinoides 2 | |
BR112019003169A2 (pt) | polietilenos modificados | |
CL2020000334A1 (es) | Formas cristalinas de 2-[(2,4-diclorofenil)metil]-4,4-dimetil-isoxazolidin-3-ona. | |
CO2021000884A2 (es) | Composiciones de esterquat | |
CL2021001044A1 (es) | Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrización de heridas y la recuperación posoperatoria | |
AR112466A1 (es) | Complejo cosmético para la hidratación bioactiva, composición cosmética, uso y método | |
BR112017015999A2 (pt) | composição espumável, espuma, e, método para preparar a mesma. | |
CL2019002840A1 (es) | Formas cristalinas de (s)-afoxolaner. | |
CO2021001174A2 (es) | Inhibidores de ckd8/19 | |
CL2020002959A1 (es) | Tratamiento de enfermedades asociadas con el envejecimiento con moduladores de la leucotrieno a4 hidrolasa. | |
CL2019002020A1 (es) | Una composición farmacéutica que comprende un derivado de oxazina y su uso en el tratamiento o la prevención de la enfermedad de alzheimer. | |
CO2022013603A2 (es) | Composiciones y método para utilizarlas para el tratamiento de enfermedades neurodegenerativas y mitocondriales |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
104 | Application deemed to be withdrawn (no substantive examination fee paid) |
Effective date: 20240815 |